Replies to post #112529 on Biotech Values

[DewDiligence]

(InPlay)—GIVN beats by $0.06, beats on revs; guides FY11 EPS below consensus, revs in-line (http://finance.yahoo.com/marketupdate/inplay#givn ):

19.17 +0.38 : Reports Q4 (Dec) GAAP earnings of $0.11 per share, $0.06 better than the Thomson Reuters consensus of $0.05; revenues rose 12.3% year/year to $44.9 mln vs the $41.7 mln consensus.

Co issues mixed guidance for FY11, GAAP sees EPS of $0.35-0.40 vs. $0.41 Thomson Reuters consensus; sees FY11 revs of $165-173 mln vs. $166.54 mln Thomson Reuters consensus.

GIVN’s own PR is at http://finance.yahoo.com/news/Given-Imaging-Reports-Fourth-iw-2529064442.html?x=0&.v=1 . The 4Q10 CC is tomorrow (Wed) at 9am ET.

[genisi]

Given Imaging receives FDA clearance for expanded PillCam SB indications

http://finance.yahoo.com/news/Given-Imaging-Receives-FDA-iw-2710730402.html?x=0&.v=1